UBS Group’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.76M Buy
772,295
+657,600
+573% +$3.2M ﹤0.01% 3299
2025
Q1
$424K Buy
114,695
+20,228
+21% +$74.8K ﹤0.01% 4787
2024
Q4
$378K Buy
94,467
+82,471
+687% +$330K ﹤0.01% 4877
2024
Q3
$83.6K Buy
11,996
+5,126
+75% +$35.7K ﹤0.01% 5288
2024
Q2
$39K Sell
6,870
-7,379
-52% -$41.8K ﹤0.01% 5734
2024
Q1
$190K Buy
14,249
+10,225
+254% +$136K ﹤0.01% 4744
2023
Q4
$24.7K Buy
4,024
+4,009
+26,727% +$24.6K ﹤0.01% 5769
2023
Q3
$38 Sell
15
-178
-92% -$451 ﹤0.01% 7900
2023
Q2
$1.01K Buy
193
+27
+16% +$142 ﹤0.01% 6954
2023
Q1
$787 Hold
166
﹤0.01% 7802
2022
Q4
$893 Sell
166
-1
-0.6% -$5 ﹤0.01% 8842
2022
Q3
$1K Hold
167
﹤0.01% 8918
2022
Q2
$2K Hold
167
﹤0.01% 8564
2022
Q1
$3K Sell
167
-2,600
-94% -$46.7K ﹤0.01% 8419
2021
Q4
$72K Buy
2,767
+2,360
+580% +$61.4K ﹤0.01% 5513
2021
Q3
$15K Buy
407
+55
+16% +$2.03K ﹤0.01% 6377
2021
Q2
$19K Sell
352
-439
-55% -$23.7K ﹤0.01% 6302
2021
Q1
$66K Sell
791
-270
-25% -$22.5K ﹤0.01% 5288
2020
Q4
$121K Buy
1,061
+883
+496% +$101K ﹤0.01% 4585
2020
Q3
$5K Sell
178
-748
-81% -$21K ﹤0.01% 6452
2020
Q2
$40K Sell
926
-3,028
-77% -$131K ﹤0.01% 5228
2020
Q1
$141K Sell
3,954
-1,094
-22% -$39K ﹤0.01% 4151
2019
Q4
$337K Sell
5,048
-377
-7% -$25.2K ﹤0.01% 4217
2019
Q3
$842K Buy
5,425
+2,747
+103% +$426K ﹤0.01% 3316
2019
Q2
$231K Sell
2,678
-270
-9% -$23.3K ﹤0.01% 4023
2019
Q1
$407K Sell
2,948
-4,889
-62% -$675K ﹤0.01% 3474
2018
Q4
$3.15M Buy
7,837
+4,642
+145% +$1.87M ﹤0.01% 2062
2018
Q3
$2.26M Buy
3,195
+503
+19% +$356K ﹤0.01% 2524
2018
Q2
$1.44M Buy
2,692
+1,973
+274% +$1.05M ﹤0.01% 2791
2018
Q1
$81K Buy
+719
New +$81K ﹤0.01% 4530